The research interests of this laboratory are focused on understanding the structure and functions of proteins encoded by gene 1 of the coronavirus mouse hepatitis virus (MHV-A59). The mouse hepatitis viruses are important models for the study of human demyelinating neurological diseases such as multiple sclerosis, as well as for investigation of the molecular biology of coronavirus replication. Although transcription and replication of the coronavirus genome has been investigated in depth, much less is known about the gene 1-encoded nonstructural proteins predicted to account for these activities. Gene 1 comprises the 5' two- thirds of the 32kb MHV genome RNA and potentially encodes 800 kDa of polypeptide in its two overlapping reading frames. Gene 1 contains conserved RNA sequences, predicting proteins with strong similarity to proteinase, replicase, and helicase proteins of other RNA viruses. Gene 1 also contains large regions of sequence(10kb) encoding polypeptides for which there are no known viral or cellular homologs. We have thus far characterized in MHV infected cells the translation and proteolytic processing of the N-terminal 380 kDa of gene 1-encoded products. The principal focus of this project will be to complete the description of the all of the distinct precursors and products encoded in gene 1. Antibodies directed against polypeptides encoded in gene 1 will be used to characterize the intracellular translation, processing, alignment, and N-terminal amino acid sequence of gene 1 proteins in MHV-A59 infected murine cell monolayers. The data on intracellular expression and processing will be utilized to investigate translation of gene 1 in cell- free lysates, in order to more specifically define the effects of proteinase inhibitors, cellular proteins, and membranes on the expression and processing of gene 1 proteins. Since reticulocyte lysates supplemented with cell extracts. The data obtained from these experiments will be used in the initial functional studies of gene 1 products, which will focus on the predict protease activities precursor proteins, both in cells and in cell-free lysates, with concomitant inhibition of virus RNA synthesis and inhibitors leupeptin and E64d. Gene 1 polyprotein processing of proteinase inhibitor-resistant various will compared with that observed in nonresistant parental MHV-A59 strains, and the sequences of predicted proteinase domains from resistant variants will be determined. These variants will allow us to define the regions of gene 1 important for proteolytic processing. This systematic investigation of gene 1 translation and processing will provide important insights into mechanisms of coronavirus replication, as well as identifying potential targets for antiviral intervention. The data will also further our long-term goal of expressing and purifying individual proteins of MHV gene 1, in order to define their unique functions and interactions during coronavirus replication.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI026603-10
Application #
2633471
Study Section
Experimental Virology Study Section (EVR)
Project Start
1991-09-30
Project End
1999-02-28
Budget Start
1998-01-01
Budget End
1999-02-28
Support Year
10
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pediatrics
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Athmer, Jeremiah; Fehr, Anthony R; Grunewald, Matthew et al. (2017) In Situ Tagged nsp15 Reveals Interactions with Coronavirus Replication/Transcription Complex-Associated Proteins. MBio 8:
St John, Sarah E; Anson, Brandon J; Mesecar, Andrew D (2016) X-Ray Structure and Inhibition of 3C-like Protease from Porcine Epidemic Diarrhea Virus. Sci Rep 6:25961
Mounce, Bryan C; Cesaro, Teresa; Moratorio, Gonzalo et al. (2016) Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses. J Virol 90:9683-9692
St John, Sarah E; Tomar, Sakshi; Stauffer, Shaun R et al. (2015) Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4--The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS). Bioorg Med Chem 23:6036-48
Smith, Everett Clinton; Case, James Brett; Blanc, Hervé et al. (2015) Mutations in coronavirus nonstructural protein 10 decrease virus replication fidelity. J Virol 89:6418-26
Tomar, Sakshi; Johnston, Melanie L; St John, Sarah E et al. (2015) Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS. J Biol Chem 290:19403-22
St John, Sarah E; Therkelsen, Matthew D; Nyalapatla, Prasanth R et al. (2015) X-ray structure and inhibition of the feline infectious peritonitis virus 3C-like protease: Structural implications for drug design. Bioorg Med Chem Lett 25:5072-7
Deng, Xufang; StJohn, Sarah E; Osswald, Heather L et al. (2014) Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistance. J Virol 88:11886-98
Agnihothram, Sudhakar; Yount Jr, Boyd L; Donaldson, Eric F et al. (2014) A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant. MBio 5:e00047-14
Jacobs, Jon; Grum-Tokars, Valerie; Zhou, Ya et al. (2013) Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL pr J Med Chem 56:534-46

Showing the most recent 10 out of 28 publications